Published in J Neurosci on April 01, 2001
Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev (2008) 2.75
Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci (2010) 1.37
The changing balance of brainstem-spinal cord modulation of pain processing over the first weeks of rat postnatal life. J Physiol (2009) 1.31
Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol Pain (2011) 1.15
Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci (2008) 1.14
Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience (2007) 1.09
Persistent pain model reveals sex difference in morphine potency. Am J Physiol Regul Integr Comp Physiol (2006) 1.08
NMDA receptor-mediated activation of medullary pro-nociceptive neurons is required for secondary thermal hyperalgesia. Pain (2006) 0.99
A critical period in the supraspinal control of pain: opioid-dependent changes in brainstem rostroventral medulla function in preadolescence. Pain (2012) 0.95
Trafficking of central opioid receptors and descending pain inhibition. Mol Pain (2007) 0.92
Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception. Neuroscience (2009) 0.91
Substance P enhances excitatory synaptic transmission on spinally projecting neurons in the rostral ventromedial medulla after inflammatory injury. J Neurophysiol (2009) 0.91
Cellular basis for opioid potentiation in the rostral ventromedial medulla of rats with persistent inflammatory nociception. Pain (2010) 0.89
Endogenous analgesia, dependence, and latent pain sensitization. Curr Top Behav Neurosci (2014) 0.88
In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay. Br J Pharmacol (2006) 0.87
Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway. J Neurosci (2012) 0.86
Differential modulation of neurons in the rostral ventromedial medulla by neurokinin-1 receptors. J Neurophysiol (2011) 0.82
Activity of murine raphe magnus cells predicts tachypnea and on-going nociceptive responsiveness. J Neurophysiol (2007) 0.81
Antinociceptive activity of methanolic extract of Muntingia calabura leaves: further elucidation of the possible mechanisms. BMC Complement Altern Med (2014) 0.80
Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors. J Neurosci (2015) 0.79
The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence. Exp Neurol (2015) 0.78
Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats. Neuropharmacology (2009) 0.77
Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation. J Neurosci (2016) 0.76
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain. J Neurosci (2017) 0.76
Plasticity in Brainstem Mechanisms of Pain Modulation by Nicotinic Acetylcholine Receptors in the Rat. eNeuro (2017) 0.75
Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci (2001) 2.79
The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci (2000) 1.48
Changes in expression of sensory organ-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation. Neuroscience (2009) 1.38
Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin. J Med Chem (1992) 1.20
Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience (2003) 1.05
Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J Neurosci (1994) 1.02
Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther (1997) 1.01
Spinal nerve ligation does not alter the expression or function of GABA(B) receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience (2006) 1.01
Peripheral and central substrates involved in the rostrad transmission of nociceptive information. Pain (1982) 0.99
Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine. Brain Res (1984) 0.99
Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol (1985) 0.98
Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther (2000) 0.97
Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold. Eur J Pharmacol (1984) 0.96
Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the beta3 subunit of the GABA(A) receptor. Neuroscience (2000) 0.94
Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. Brain Res (1985) 0.93
Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur J Pharmacol (1983) 0.92
Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther (1994) 0.92
Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information. Fed Proc (1981) 0.91
Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception. Neuroscience (2009) 0.91
A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain (2001) 0.89
Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat. J Pharmacol Exp Ther (1999) 0.87
GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat. Brain Res (1988) 0.85
Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth (2003) 0.85
Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists. Brain Res (1981) 0.85
Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. J Pharmacol Exp Ther (1993) 0.84
Microinjection of morphine into the rat medullary dorsal horn produces a dose-dependent increase in facial scratching. Brain Res (1995) 0.84
Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat. J Pharmacol Exp Ther (1991) 0.83
Intrathecal administration: methodological considerations. Prog Brain Res (1988) 0.82
The antinociceptive effects of prostaglandin antagonists in the rat. Eur J Pharmacol (1987) 0.81
Antagonism of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not delta-aminovaleric acid in the rat. J Pharmacol Exp Ther (1991) 0.81
Synergistic interactions between two alpha(2)-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats. Pain (2000) 0.81
Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus. Pain (1980) 0.81
Observations on the marine leech Calliobdella carolinensis (Hirudinea: Piscicolidae), epizootic on the Atlantic menhaden. Biol Bull (1973) 0.80
Antinociception produced by microinjection of L-glutamate into the ventromedial medulla of the rat: mediation by spinal GABAA receptors. Brain Res (1993) 0.80
Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats. J Pharmacol Exp Ther (1997) 0.80
Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses. J Pharmacol Exp Ther (1995) 0.80
Releases of norepinephrine and dopamine in ventriculocisternal perfusions in hepatectomized and laparotomized rats. J Neurochem (1996) 0.79
Antinociception after intracerebroventricular administration of naltrindole in the mouse. Eur J Pharmacol (1992) 0.79
Differential distribution of (GABA)A receptor subunits on bulbospinal serotonergic and nonserotonergic neurons of the ventromedial medulla of the rat. J Comp Neurol (1997) 0.79
Supraspinal and spinal delta(2) opioid receptor-mediated antinociceptive synergy is mediated by spinal alpha(2) adrenoceptors. Pain (1999) 0.79
Peripheral and central pathways in pain. Pharmacol Ther (1981) 0.78
Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J Pharmacol Exp Ther (1997) 0.78
Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide. J Med Chem (1994) 0.78
Intrathecal GABAB antagonists attenuate the antinociception produced by microinjection of L-glutamate into the ventromedial medulla of the rat. Brain Res (1993) 0.78
Drug-induced alterations in the efflux of 5-hydroxytryptamine and of 5-hydroxyindoleacetic acid into superfusates of the rat spinal cord. Eur J Pharmacol (1983) 0.77
Delta antagonist and kappa agonist activity of Naltriben: evidence for differential kappa interaction with the delta 1 and delta 2 opioid receptor subtypes. Life Sci (1994) 0.77
Hypoalgesia induced by microinjection of a norepinephrine antagonist in the raphe magnus: reversal by intrathecal administration of a serotonin antagonist. Brain Res (1980) 0.77
Effect of embryonic knock-down of GABAA receptors on the levels of monoamines and their metabolites in the CNS of the mouse. Brain Res (2001) 0.76
Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats. Brain Res (1996) 0.76
Concurrent measurement of substance P and serotonin in spinal superfusates: failure of capsaicin and p-chloroamphetamine to co-release. Brain Res (1983) 0.75
Conjugates of dopamine and serotonin in ventriculocisternal perfusates of the cat. J Neurochem (1984) 0.75
Intrathecal bicuculline does not increase formalin-induced inflammation. Brain Res (1998) 0.75
Intermittent shock titration task in the rhesus monkey and its validity as an analgesiometric procedure. Brain Res (1989) 0.75
Antagonism of the antinocifensive action of halothane by intrathecal administration of GABAA receptor antagonists. Anesthesiology (1996) 0.75
Presence of conjugated 5-hydroxytryptamine in in vivo superfusates of rat spinal cord. J Neurochem (1981) 0.75
Effects of locus coeruleus lesions on morphine-induced antinociception. Brain Res (1980) 0.75
Shock titration in the rhesus monkey: effects of opiate and nonopiate analgesics. J Pharmacol Exp Ther (1985) 0.75